12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Deals

Cytokinetics, MyoKardia deal

Cytokinetics said it received an equity stake in MyoKardia in exchange for patent rights related to Cytokinetics' cardiac sarcomere inhibitor program for hypertrophic cardiomyopathies. Under a one-year research...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >